OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0000949699

PHARMACYCLICS INC

PHARMACYCLICS INC (CIK 0000949699, EIN 94-3148201) reported revenue of $729.73 million ($729,729,000) for FY2014 (2014-01-01 to 2014-12-31) and net income of $86.12 million ($86,124,000) for FY2014 (2014-01-01 to 2014-12-31), as filed in its 10-K filed 2015-02-18 (accession 0001628280-15-000826).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000949699
EIN94-3148201
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_5j3c1vc4xg1arf0jtap39ze7b5
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$729,729,000FY20142014-01-01 to 2014-12-3110-K2015-02-180001628280-15-000826Revenues
Net income$86,124,000FY20142014-01-01 to 2014-12-3110-K2015-02-180001628280-15-000826NetIncomeLoss
Total assets$1,060,107,000FY2014as of 2014-12-3110-K2015-02-180001628280-15-000826Assets
Total liabilities$230,942,000FY2014as of 2014-12-3110-K2015-02-180001628280-15-000826Liabilities
Stockholders' equity$829,165,000FY2014as of 2014-12-3110-K2015-02-180001628280-15-000826StockholdersEquity
Operating cash flow$183,767,000FY20142014-01-01 to 2014-12-3110-K2015-02-180001628280-15-000826NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$1.1 per shareFY20142014-01-01 to 2014-12-3110-K2015-02-180001628280-15-000826EarningsPerShareDiluted
Shares outstanding76,016,912 sharesFY2014as of 2015-02-1210-K2015-02-180001628280-15-000826EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2005-2014, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20142014-01-01 to 2014-12-31$729,729,00010-K2015-02-180001628280-15-000826
RevenueFY20132013-01-01 to 2013-12-31$260,169,00010-K2015-02-180001628280-15-000826
RevenueFY20122011-07-01 to 2012-06-30$81,990,00010-K2015-02-180001628280-15-000826
Net incomeFY20142014-01-01 to 2014-12-31$86,124,00010-K2015-02-180001628280-15-000826
Net incomeFY20132013-01-01 to 2013-12-31$67,010,00010-K2015-02-180001628280-15-000826
Net incomeFY20122011-07-01 to 2012-06-30$11,986,00010-K2015-02-180001628280-15-000826

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2015-05-042015-03-310001628280-15-003587pcyc20150331_q1x10-q.htm
10-K/A2015-04-082014-12-310000921895-15-000899form10ka107380004_12312014.htm
10-K2015-02-182014-12-310001628280-15-000826pcyc20141231-10xk.htm
10-Q2014-11-072014-09-300001445305-14-004960pcyc20140930_q3x10-q.htm
10-Q2014-08-082014-06-300001445305-14-003519pcyc20140630_q2x10-q.htm
10-Q2014-05-082014-03-310001445305-14-001952pcyc20140331_q4x10-q.htm
10-K2014-02-262013-12-310001445305-14-000625a20131231-10xk.htm
10-Q2013-11-072013-09-300001445305-13-002836pcyc20130930_q3x10-q.htm
10-Q2013-08-082013-06-300001445305-13-002027pcyc2013063010-q.htm
10-Q2013-05-072013-03-310001445305-13-001176pcyc2013033110-q.htm
10-K2013-02-262012-12-310001445305-13-000345a201210-k.htm
10-Q2012-11-072012-09-300001445305-12-003519pcyc2013093010-q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000949699published by the sourcedata.sec.gov/submissions/CIK0000949699.json2026-10-21
Employer Identification Number (EIN) · US-EIN94-3148201published by the sourcedata.sec.gov/submissions/CIK0000949699.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000949699.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000949699.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000949699" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000949699/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000949699/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"949699"}

On SEC EDGAR

About this data